A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients
Corresponding Author
Cristina Solomon
Cristina Solomon, Department of Anaesthesiology and Intensive Care, Salzburger Landeskliniken SALK, 48 Müllner Hauptstrasse, 5020 Salzburg, Austria; e-mail: [email protected]. Search for more papers by this authorJanne Cadamuro
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorBernhard Ziegler
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorHerbert Schöchl
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorMichael Varvenne
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorBenny Sørensen
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorGerald Hochleitner
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorNiels Rahe-Meyer
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorCorresponding Author
Cristina Solomon
Cristina Solomon, Department of Anaesthesiology and Intensive Care, Salzburger Landeskliniken SALK, 48 Müllner Hauptstrasse, 5020 Salzburg, Austria; e-mail: [email protected]. Search for more papers by this authorJanne Cadamuro
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorBernhard Ziegler
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorHerbert Schöchl
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorMichael Varvenne
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorBenny Sørensen
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorGerald Hochleitner
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorNiels Rahe-Meyer
From the Department of Anaesthesiology and Intensive Care and the Institute of Medical and Chemical Laboratory Diagnostics, Salzburger Landeskliniken SALK, Salzburg, Austria; the Department of Anaesthesiology and Intensive Care Medicine and the Department of Haematology, Hannover Medical School, Hannover, Germany; the Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria; the Department of Anaesthesiology and Intensive Care, AUVA Trauma Centre, Salzburg, Austria; the Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, United Kingdom; the Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark; CSL Behring, Vienna, Austria; and the Department of Anaesthesiology and Intensive Care Medicine, Franziskus Hospital, Bielefeld, Germany.
Search for more papers by this authorAbstract
BACKGROUND: Fibrinogen concentrate administration can be guided by measuring fibrinogen concentration or quality of the fibrin-based clot. This study compared different fibrinogen concentration measurement methods with maximum clot firmness (MCF) of the fibrin clot, assessed by thromboelastometry (FIBTEM), in 33 cardiovascular surgery patients receiving fibrinogen concentrate for hemostatic therapy.
STUDY DESIGN AND METHODS: Blood samples were collected after cardiopulmonary bypass (CPB) and after fibrinogen concentrate administration. FIBTEM MCF was measured using a rotational thromboelastometry device (ROTEM, Tem International). Fibrinogen concentration was measured using photo-optical (CA-7000, Siemens Healthcare Diagnostics), mechanical (KC-10 steel ball, Schnitger and Gross hook, Amelung GmbH), and electromechanical (STA-R, Diagnostica Stago) coagulometers. Assessments included agreement between fibrinogen concentration measurements and correlations between fibrinogen concentration and FIBTEM MCF.
RESULTS: After CPB, correlations were significant (p < 0.001) between FIBTEM MCF and fibrinogen concentration determined by steel ball (r = 0.71), hook (r = 0.73), STA-R (r = 0.81), and CA-7000 (r = 0.82) coagulometers. After fibrinogen concentrate administration, agreement between fibrinogen measurement methods was severely impaired, and correlations with FIBTEM MCF were 0.39 (steel ball), 0.33 (hook), 0.59 (STA-R), and 0.33 (CA-7000).
CONCLUSION: Agreement between fibrinogen concentration measurement methods decreased considerably after fibrinogen concentrate administration. All methods correlated acceptably with FIBTEM MCF at the end of CPB, but not after hemostatic therapy. Further investigation is needed to explain these findings.
REFERENCES
- 1 Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate—a potential universal hemostatic agent. Expert Opin Biol Ther 2009; 9: 1325-33.
- 2 Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009; 138: 694-702.
- 3 Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009; 102: 785-92.
- 4 Schochl H, Posch A, Hanke A, Voelckel W, Solomon C. High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake. Scand J Clin Lab Invest 2010; 70: 453-7.
- 5 Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
- 6 Danes AF, Cuenca LG, Bueno SR, Mendarte BL, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008; 94: 221-6.
- 7 Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802.
- 8 Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008; 18: 151-7.
- 9 Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010; 24: 27-40.
- 10 Weinstock N, Ntefidou M. SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniques. J Thromb Haemost 2006; 4: 1825-7.
- 11 Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010; 50: 2571-6.
- 12 Hirai N, Tatsumi N, Hino M, Yamane T, Ohta K. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data. Osaka City Med J 1998; 44: 55-71.
- 13 Kretschmer V, Daraktchiev A, Bade S, Karger R, Kratzer MA. Does hemodilution enhance coagulability? Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 751-6.
- 14 Lawrie AS, McDonald SJ, Purdy G, Mackie IJ, Machin SJ. Prothrombin time derived fibrinogen determination on Sysmex CA-6000. J Clin Pathol 1998; 51: 462-6.
- 15 Bovill EG, McDonagh J, Triplett DA, Arkin CF, Brandt JT, Hayes TE, Kaczmarek E, Long T, Rock WA. Performance characteristics of fibrinogen assays. Results of the College of American Pathologists Proficiency Testing Program 1988-1991. Arch Pathol Lab Med 1993; 117: 58-66.
- 16 Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5.
- 17 Halbmayer WM, Haushofer A, Schon R, Radek J, Fischer M. Comparison of a new automated kinetically determined fibrinogen assay with the 3 most used fibrinogen assays (functional, derived and nephelometric) in Austrian laboratories in several clinical populations and healthy controls. Haemostasis 1995; 25: 114-23.
- 18 Siefring GE Jr, Riabov DK, Wehrly JA. Development and analytical performance of a functional assay for fibrinogen on the Du Pont aca analyzer. Clin Chem 1983; 29: 614-7.
- 19
Marbet GA,
Duckert F.
Fibrinogen. In: J Jesperson,
RM Bertina,
F Haverkate, editors. ECAT assay procedures. Dordrecht/Boston (MA)/London: Kluwer Academic Publishers; 1992. p. 47-55.
10.1007/978-94-011-2992-3_6 Google Scholar
- 20 Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-46.
- 21 Rumley A, Woodward M, Hoffmeister A, Koenig W, Lowe GD. Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population: implications for risk stratification by thirds of fibrinogen. Blood Coagul Fibrinolysis 2003; 14: 197-201.
- 22 Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104: 555-62.
- 23 Schnitger H, Gross R. A universal apparatus for automatic recording of the clotting time. Klin Wochenschr 1954; 32: 1011-2.
- 24 Paar D. Messverfahren mechanisierter systeme zur durchführung von gerinnungsuntersuchungen. Hämostaseologie 1991; 11: 1-3.
- 25 Crespo B, Ankri A, Lesty C. Evaluation of the KC10 semi-automatic modular clot detection device. Nouv Rev Fr Hematol 1983; 25: 113-21.
- 26 van den Besselaar AM, Haas FJ, van der Graaf F, Kuypers AW. Harmonization of fibrinogen assay results: study within the framework of the Dutch project “Calibration 2000.” Int J Lab Hematol 2009; 31: 513-20.
- 27 Chantarangkul V, Tripodi A, Mannucci PM. Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement. Blood Coagul Fibrinolysis 1994; 5: 761-6.
- 28 Takamiya O, Hando S, Tekondo M, Bando S, Ohkura M, Negoro T, Yoshida T, Higashi K, Ohnuma O, Kubota K, Tatsumi N. Japanese collaborative study for fibrinogen assay: variability of the fibrinogen assay between different laboratories does not improve when a common calibrator is used. Clin Lab Haematol 2005; 27: 177-83.
- 29 Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Klingler A, Klima G, Martinowitz U, Fries D. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007; 5: 1019-25.
- 30 Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19: 212-9.
- 31 Lee SH, Lee SM, Kim CS, Cho HS, Kim GS, Gwak MS, Chang CH, Sung K. Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass. Blood Coagul Fibrinolysis 2010; 21: 687-91.
- 32 Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-95.
- 33 Hartert H, Schaeder JA. The physical and biological constants of thrombelastography. Biorheology 1962; 1: 31-9.
- 34 Mackie IJ, Kitchen S, Machin SJ, Lowe GD. Guidelines on fibrinogen assays. Br J Haematol 2003; 121: 396-404.
- 35 Adam S, Karger R, Kretschmer V. Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost 2010; 16: 454-60.
- 36
Henschen-Edman AH.
Human fibrinogen occurs as over 1 million non-identical molecules. In: MZ Atassi,
F Appella, editors. Methods in protein structure analysis. New York: Plenum Press; 1995. p. 435-43.
10.1007/978-1-4899-1031-8_39 Google Scholar
- 37 Mosesson MW, DiOrio JP, Hernandez I, Hainfeld JF, Wall JS, Grieninger G. The ultrastructure of fibrinogen-420 and the fibrin-420 clot. Biophys Chem 2004; 112: 209-14.
- 38 Nieuwenhuizen W. Biochemistry and measurement of fibrinogen. Eur Heart J 1995; 16(Suppl A): 6-10.
- 39 American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208.
- 40 Geeraedts LM Jr, Demiral H, Schaap NP, Kamphuisen PW, Pompe JC, Frolke JP. “Blind” transfusion of blood products in exsanguinating trauma patients. Resuscitation 2007; 73: 382-8.
- 41 Frith D, Brohi K. The acute coagulopathy of trauma shock: clinical relevance. Surgeon 2010; 8: 159-63.
- 42 Jeger V, Urwyler N, Zimmermann H, Exadaktylos AK. Trauma-induced coagulopathy in severely injured patients: knowledge lost in translation? Emerg Med J 2010; 27: 551-2.
- 43 Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007; 73: 401-15.
- 44 Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100: 792-7.
- 45 Plotkin AJ, Wade CE, Jenkins DH, Smith KA, Noe JC, Park MS, Perkins JG, Holcomb JB. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008; 64(Suppl): S64-S68.
- 46 Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009; 101: 394-401.
- 47 Chandler WL, Ferrell C, Trimble S, Moody S. Development of a rapid emergency hemorrhage panel. Transfusion 2010; 50: 2547-52.
- 48 Boudaoud L, Divaret G, Marie P, Bezeaud A. Rapid centrifugation for routine coagulation testing. Ann Biol Clin (Paris) 2006; 64: 315-7.
- 49 Jeger V, Zimmermann H, Exadaktylos AK. Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries? J Trauma 2009; 66: 1253-7.
- 50 Savry C, Quinio P, Lefèvre F, Schmitt F. Maniability and potential interests of haemostasis monitoring by near-patient modified thromboelastometer (Rotem™) in intensive care unit. Ann Fr Anesth Reanim 2005; 24: 607-16.
- 51 Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz RC. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009; 116: 1097-102.
- 52 McNerlan SE, Crawford VL, Stout RW. Measurement of fibrinogen in frozen plasma. Thromb Res 1997; 88: 481-4.
Citing Literature
